Payments to Patients, Members of the Public & Media

Bayer is committed to communicating appropriately about new and innovative therapies for severe and chronic diseases. Patients speaking about their experiences with their disease, members of the public lending their expertise and media amplifying new developments in medicine, help to generate awareness about diseases and effective interventions.

The most recent patients, members of the public and media to which Bayer has provided financial support are listed below.

TOV disclosure for members of the public 2024

COR-OTH-GB-0066 / June 2025

 

Correct at 16 June 2025